MedTrace Logo

Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR）

NCT05965362 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-07-12

No results posted yet for this study

Summary

In this study, by establishing a clinical cohort of infective endocarditis, we observed the natural prognosis and influencing factors in the process of disease development and regression; we used multi-omics technology to understand the prognostic value of its biomarkers, and provided new ideas and evidence for the pathogenesis, clinical diagnosis and treatment of IE.

Conditions

  • Infective Endocarditis

Interventions

OTHER

Observational; No Interventions were given.

Observational; No Interventions were given.

Sponsors & Collaborators

  • 521 Hospital of NORINCO Group

    collaborator OTHER

  • Shaanxi Provincial People's Hospital

    collaborator OTHER

  • Xiangyang Central Hospital

    collaborator OTHER

  • Henan Provincial People's Hospital

    collaborator OTHER

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Yang Yan · First Affiliated Hospital Xi'an Jiaotong University

  • Guoliang Li · First Affiliated Hospital Xi'an Jiaotong University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-09
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05965362 on ClinicalTrials.gov